MedTrace Logo

Left Atrial Appendage (LAA) Clot With Severe Mitral Stenosis

NCT05186649 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2022-01-11

No results posted yet for this study

Summary

Consecutive patients with severe mitral stenosis and clot in left atrial appendage (LAA) on transesophageal echocardiography fulfilling the inclusion criteria will be recruited for this study. An ACUSON 128-XP echocardiographic system equipped with omniplane and biplane transesophageal probes will be used for this study. TEE followed by CT Angiography will be performed according to the standard procedure after obtaining informed consent.

Conditions

  • Left Atrial Appendage Aneurysm
  • Mitral Stenosis

Interventions

OTHER

WARFARIN

5 mg of daily dosage

Sponsors & Collaborators

  • Advanced Education & Research Center

    collaborator OTHER

  • Karachi Institute of Heart Diseases

    collaborator NETWORK

  • University of Karachi

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-06-30
Completion
2022-07-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05186649 on ClinicalTrials.gov